Scholarly Index
Paul Lorigan
The Christie NHS Foundation Trust; 62,548 total citations; 567 total publications; best world rank #81
The Christie NHS Foundation Trust
62,548Total citations
567Total publications
87H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Immunotherapy and Biomarkers | Lifetime | 173 | GB 5 | 99.56 |
| CAR-T cell therapy research | Lifetime | 152 | GB 6 | 99.43 |
| Lung Cancer Research Studies | Lifetime | 225 | GB 11 | 99.04 |
| Cutaneous Melanoma Detection and Management | Lifetime | 107 | GB 5 | 98.95 |
| Melanoma and MAPK Pathways | Lifetime | 81 | GB 4 | 99.03 |
| Neuroendocrine Tumor Research Advances | Lifetime | 379 | GB 25 | 98.60 |
| Cancer therapeutics and mechanisms | Lifetime | 500 | GB 34 | 97.43 |
| Gestational Trophoblastic Disease Studies | Lifetime | 275 | GB 33 | 91.73 |
| Synthesis of Tetrazole Derivatives | Lifetime | 798 | GB 23 | 73.01 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 190 | GB 5 | 99.28 |
| CAR-T cell therapy research | 2021-2025 | 502 | GB 9 | 96.93 |
| Melanoma and MAPK Pathways | 2021-2025 | 95 | GB 2 | 94.75 |
| Cutaneous Melanoma Detection and Management | 2021-2025 | 200 | GB 3 | 94.13 |
| Immunotherapy and Immune Responses | 2021-2025 | 985 | GB 24 | 90.85 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 690 | GB 13 | 78.38 |